ORGO Organogenesis Holdings Inc.
Nasdaq · SEC CIK 1661181 · EDGAR
- Bought, last 12 months
- $40.1K 2 purchases by 2 insiders
- Sold, last 12 months
- $2.62M 2 sales by 1 insiders
- Filings on record
- 174 since 2021-07-20, latest 2026-04-24 21:29
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| NUSSDORF GLENN H | Dir, 10% | — | $2.62M |
| Driscoll Michael Joseph | Dir | $26.7K | — |
| Leibowitz Arthur S | Dir | $13.4K | — |
| Lustig Garrett | Dir | — | — |
| Cavorsi Robert | VP, Strategy | — | — |
| Quintero Gilberto | Dir | — | — |
| Francisco David | CFO | — | — |
| Duraibabu Prathyusha | Dir | — | — |
| Korfin Michele Ilene | Dir | — | — |
| Montecalvo Antonio S. | VP, Health Policy | — | — |
Transactions 214
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-24 21:29 | 2025-01-10 | ORGO | Grow Brian | Chief Commercial Off | M - OptEx | $1.24 | +958 | 900.7K | +0.1% | +$1,188 |
| 2026-03-11 | 2026-03-09 | ORGO | Leibowitz Arthur S | Dir | P - Purchase | $2.68 | +5,000 | 291.0K | +2% | +$13.4K | |
| 2026-03-11 | 2026-03-09 | ORGO | Driscoll Michael Joseph | Dir | P - Purchase | $2.67 | +10.0K | 225.7K | +5% | +$26.7K | |
| A | 2026-03-03 | 2026-02-18 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $3.84 | -11.9K | 899.7K | -1% | -$45.6K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +48.8K | 911.6K | +6% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Cavorsi Robert | VP, Strategy | A - Grant | $0.00 | +16.5K | 281.7K | +6% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.84 | -5,487 | 276.2K | -2% | -$21.1K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.84 | -91.3K | 4.23M | -2% | -$350.6K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +188.9K | 4.32M | +5% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.84 | -3,778 | 226.2K | -2% | -$14.5K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +11.3K | 230.0K | +5% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | A - Grant | $0.00 | +43.2K | 1.04M | +4% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $3.84 | -14.4K | 1.02M | -1% | -$55.3K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Francisco David | CFO | F - Tax | $3.84 | -14.7K | 731.3K | -2% | -$56.4K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Francisco David | CFO | A - Grant | $0.00 | +44.0K | 746.0K | +6% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +49.1K | 1.14M | +4% | $0 |
| A | 2026-03-03 | 2026-02-18 | ORGO | Bilbo Patrick | COO | F - Tax | $3.84 | -16.4K | 1.13M | -1% | -$62.9K |
| 2026-03-03 | 2026-03-01 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.21 | -700 | 275.5K | -0.3% | -$2,247 | |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | A - Grant | $0.00 | +245.9K | 994.8K | +33% | $0 |
| D | 2026-02-20 | 2026-02-18 | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $3.84 | -14.3K | 1.02M | -1% | -$54.8K |
| 2026-02-20 | 2026-02-18 | ORGO | Korfin Michele Ilene | Dir | A - Grant | $0.00 | +48.8K | 239.1K | +26% | $0 | |
| D | 2026-02-20 | 2026-02-18 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $3.84 | -11.8K | 899.4K | -1% | -$45.2K |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +282.7K | 911.1K | +45% | $0 |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Cavorsi Robert | VP, Strategy | A - Grant | $0.00 | +110.0K | 265.3K | +71% | $0 |
| D | 2026-02-20 | 2026-02-18 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.84 | -5,432 | 276.1K | -2% | -$20.9K |
| D | 2026-02-20 | 2026-02-18 | ORGO | Francisco David | CFO | F - Tax | $3.84 | -14.5K | 731.0K | -2% | -$55.8K |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Francisco David | CFO | A - Grant | $0.00 | +238.9K | 745.6K | +47% | $0 |
| 2026-02-20 | 2026-02-18 | ORGO | Quintero Gilberto | Dir | A - Grant | $0.00 | +48.8K | 239.1K | +26% | $0 | |
| 2026-02-20 | 2026-02-18 | ORGO | Leibowitz Arthur S | Dir | A - Grant | $0.00 | +48.8K | 286.0K | +21% | $0 | |
| 2026-02-20 | 2026-02-18 | ORGO | Giacomin Jon L | Dir | A - Grant | $0.00 | +48.8K | 241.0K | +25% | $0 | |
| 2026-02-20 | 2026-02-18 | ORGO | Driscoll Michael Joseph | Dir | A - Grant | $0.00 | +48.8K | 215.7K | +29% | $0 | |
| 2026-02-20 | 2026-02-18 | ORGO | Lustig Garrett | Dir | A - Grant | $0.00 | +48.8K | 125.7K | +63% | $0 | |
| D | 2026-02-20 | 2026-02-18 | ORGO | Bilbo Patrick | COO | F - Tax | $3.84 | -16.2K | 1.13M | -1% | -$62.3K |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +259.5K | 1.10M | +31% | $0 |
| D | 2026-02-20 | 2026-02-18 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.84 | -90.4K | 4.23M | -2% | -$347.1K |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +1.08M | 4.13M | +35% | $0 |
| 2026-02-20 | 2026-02-18 | ORGO | Duraibabu Prathyusha | Dir | A - Grant | $0.00 | +48.8K | 247.0K | +25% | $0 | |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +51.8K | 229.9K | +29% | $0 |
| D | 2026-02-20 | 2026-02-18 | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.84 | -3,741 | 226.2K | -2% | -$14.4K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.73 | -18.6K | 195.3K | -9% | -$69.4K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.73 | -17.7K | 171.5K | -9% | -$65.9K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Francisco David | CFO | F - Tax | $3.73 | -52.4K | 555.2K | -9% | -$195.6K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $3.73 | -44.0K | 628.4K | -7% | -$164.0K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $3.73 | -54.7K | 805.2K | -6% | -$204.2K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.73 | -271.4K | 3.49M | -7% | -$1.01M |
| M | 2026-02-18 | 2026-02-15 | ORGO | Bilbo Patrick | COO | F - Tax | $3.73 | -64.4K | 915.6K | -7% | -$240.3K |
| 2025-12-18 | 2025-12-16 | ORGO | NUSSDORF GLENN H | Dir | S - Sale | $5.14 | -200.0K | 2.57M | -7% | -$1.03M | |
| M | 2025-11-26 | 2025-11-24+ | ORGO | NUSSDORF GLENN H | Dir, 10% | S - Sale | $5.31 | -300.0K | 2.95M | -9% | -$1.59M |
| MI | 2025-11-03 | 2025-05-14+ | ORGO | NUSSDORF GLENN H | Dir, 10% | P - Purchase | $3.06 | +358.5K | 251.0K | New | +$1.10M |
| MI | 2025-11-03 | 2025-06-09+ | ORGO | NUSSDORF GLENN H | Dir, 10% | S - Sale | $3.55 | -22.8K | 354.3K | -6% | -$80.8K |
| D | 2025-08-13 | 2025-08-11 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $4.62 | -2,173 | 672.4K | -0.3% | -$10.0K |
| D | 2025-08-13 | 2025-08-11 | ORGO | Grow Brian | Chief Commercial Off | M - OptEx | $2.47 | +4,060 | 674.5K | +0.6% | +$10.0K |
| 2025-07-18 | 2025-07-16 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $4.47 | -360 | 189.2K | -0.2% | -$1,609 | |
| M | 2025-06-06 | 2025-06-04+ | ORGO | Freedman Lori | Chief Admin, Legal Off | P - Purchase | $2.88 | +252.3K | 846.5K | +42% | +$725.7K |
| M | 2025-03-12 | 2025-03-09 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $5.16 | -271 | 189.5K | -0.1% | -$1,398 |
| 2025-03-06 | 2025-03-04 | ORGO | Driscoll Michael Joseph | Dir | S - Sale | $5.10 | -25.0K | 166.9K | -13% | -$127.5K | |
| 2025-03-04 | 2025-03-01 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $6.21 | -667 | 189.8K | -0.4% | -$4,142 | |
| 2025-02-21 | 2025-02-19 | ORGO | Driscoll Michael Joseph | Dir | A - Grant | $0.00 | +49.6K | 191.9K | +35% | $0 | |
| 2025-02-21 | 2025-02-19 | ORGO | Leibowitz Arthur S | Dir | A - Grant | $0.00 | +49.6K | 237.2K | +26% | $0 | |
| 2025-02-21 | 2025-02-19 | ORGO | Quintero Gilberto | Dir | A - Grant | $0.00 | +49.6K | 190.2K | +35% | $0 | |
| 2025-02-21 | 2025-02-19 | ORGO | Duraibabu Prathyusha | Dir | A - Grant | $0.00 | +49.6K | 198.2K | +33% | $0 | |
| D | 2025-02-21 | 2025-02-19 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +708.2K | 3.52M | +25% | $0 |
| 2025-02-21 | 2025-02-19 | ORGO | Giacomin Jon L | Dir | A - Grant | $0.00 | +49.6K | 192.2K | +35% | $0 | |
| D | 2025-02-21 | 2025-02-19 | ORGO | Cavorsi Robert | VP, Strategy | A - Grant | $0.00 | +61.7K | 190.5K | +48% | $0 |
| D | 2025-02-21 | 2025-02-19 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +184.1K | 949.1K | +24% | $0 |
| 2025-02-21 | 2025-02-19 | ORGO | Korfin Michele Ilene | Dir | A - Grant | $0.00 | +49.6K | 190.2K | +35% | $0 | |
| D | 2025-02-21 | 2025-02-19 | ORGO | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +42.5K | 196.7K | +28% | $0 |
| 2025-02-21 | 2025-02-19 | ORGO | Lustig Garrett | Dir | A - Grant | $0.00 | +49.6K | 76.9K | +181% | $0 | |
| D | 2025-02-21 | 2025-02-19 | ORGO | Freedman Lori | Chief Admin, Legal Off | A - Grant | $0.00 | +162.0K | 594.2K | +37% | $0 |
| D | 2025-02-21 | 2025-02-19 | ORGO | Francisco David | CFO | A - Grant | $0.00 | +165.2K | 559.1K | +42% | $0 |
| D | 2025-02-21 | 2025-02-19 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +183.1K | 670.5K | +38% | $0 |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $3.70 | -37.1K | 432.8K | -8% | -$137.4K |
| M | 2025-02-19 | 2025-02-15 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.70 | -11.0K | 128.8K | -8% | -$40.7K |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.70 | -232.1K | 2.96M | -7% | -$858.7K |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $3.70 | -33.4K | 487.4K | -6% | -$123.5K |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Bilbo Patrick | COO | F - Tax | $3.70 | -44.2K | 765.7K | -5% | -$163.4K |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Francisco David | CFO | F - Tax | $3.70 | -35.1K | 394.7K | -8% | -$129.7K |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.70 | -14.1K | 154.2K | -8% | -$52.1K |
| M | 2025-01-13 | 2025-01-09 | ORGO | Albert Erani Family Trust dated 12/29/2012 | 10% | G - Gift | $0.00 | 0 | 51.09M | New | $0 |
| I | 2025-01-13 | 2025-01-09 | ORGO | Albert Erani Family Trust dated 12/29/2012 | 10% | G - Gift | $0.00 | +6.40M | 51.09M | +14% | $0 |
| I | 2025-01-13 | 2025-01-09 | ORGO | Ades Josette | 10% | G - Gift | $0.00 | +6.40M | 51.09M | +14% | $0 |
| M | 2025-01-13 | 2025-01-09 | ORGO | Ades Josette | 10% | G - Gift | $0.00 | 0 | 51.09M | New | $0 |
| I | 2025-01-03 | 2024-12-31 | ORGO | Albert Erani Family Trust dated 12/29/2012 | 10% | G - Gift | $0.00 | +1.71M | 51.09M | +3% | $0 |
| M | 2025-01-03 | 2024-12-31 | ORGO | Albert Erani Family Trust dated 12/29/2012 | 10% | G - Gift | $0.00 | 0 | 51.09M | New | $0 |
| M | 2025-01-03 | 2024-12-31 | ORGO | Ades Alan A. | Dir, 10% | G - Gift | $0.00 | 0 | 51.09M | New | $0 |
| I | 2025-01-03 | 2024-12-31 | ORGO | Ades Alan A. | Dir, 10% | G - Gift | $0.00 | +1.71M | 51.09M | +3% | $0 |
| M | 2024-12-16 | 2024-12-13+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale | $3.37 | -61.2K | 3.04M | -2% | -$206.4K |
| M | 2024-12-12 | 2024-12-10+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale | $3.62 | -259.3K | 3.30M | -7% | -$940.1K |
| DM | 2024-12-09 | 2024-12-06+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale+OE | $3.56 | -59.5K | 3.40M | -2% | -$211.7K |
| D | 2024-12-09 | 2024-12-05 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +1.07M | 3.42M | +45% | +$1.06M |
| 2024-12-02 | 2024-11-27 | ORGO | GN 2016 Family Trust u/a/d August 12, 2016 | 10% | D - Sale to Iss | $4.06 | -500.0K | 51.09M | -1.0% | -$2.03M | |
| 2024-12-02 | 2024-11-27 | ORGO | ERANI ALBERT | 10% | D - Sale to Iss | $4.06 | -500.0K | 51.09M | -1.0% | -$2.03M | |
| M | 2024-11-14 | 2024-11-12 | ORGO | ERANI ALBERT | 10% | D - Sale to Iss | $3.16 | -6.61M | 54.14M | -11% | -$20.88M |
| M | 2024-11-14 | 2024-11-12 | ORGO | ERANI ALBERT | 10% | J - Other | $3.16 | -815.0K | 58.19M | -1% | -$2.58M |
| M | 2024-11-14 | 2024-11-12 | ORGO | ERANI ALBERT | 10% | D - Sale to Iss | $3.16 | -6.61M | 57.90M | -10% | -$20.88M |
| M | 2024-11-14 | 2024-11-12 | ORGO | ERANI ALBERT | 10% | J - Other | $3.16 | -815.0K | 58.78M | -1% | -$2.58M |
| 2024-07-18 | 2024-07-16 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.09 | -317 | 139.8K | -0.2% | -$979.53 | |
| 2024-04-03 | 2024-04-01 | ORGO | Bilbo Patrick | COO | F - Tax | $2.80 | -2,497 | 809.1K | -0.3% | -$6,992 | |
| 2024-04-03 | 2024-04-01 | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $2.80 | -1,974 | 469.3K | -0.4% | -$5,527 | |
| 2024-04-03 | 2024-04-01 | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $2.80 | -1,752 | 168.3K | -1% | -$4,906 |
Purchase Sale Sale after option exercise All abbreviations